CB-03-01 cream, 1%
Sponsors
Cassiopea SpA
Conditions
Acne Vulgaris
Phase 3
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
CompletedNCT02608450
Start: 2016-01-21End: 2018-04-11Updated: 2020-11-20
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
CompletedNCT02608476
Start: 2015-11-16End: 2018-02-21Updated: 2020-11-20
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris
CompletedNCT02682264
Start: 2016-03-09End: 2018-08-31Updated: 2020-11-17